Tuberous sclerosis renal angiomyolipoma — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Refer for treatment to reduce haemorrhage risk
Large angiomyolipomas in tuberous sclerosis, particularly with aneurysmal components, carry haemorrhage risk and need specialist management such as embolisation or mTOR inhibitor therapy depending on context. Biopsy is usually avoided because imaging is characteristic and bleeding risk exists. Routine nephrectomy is kidney-sacrificing and not first-line for bilateral disease. The pearl is that preserving renal function is central because lesions are often multiple and bilateral.
Reference: Tuberous Sclerosis Complex Consensus guidance; Renal Medicine 2022 Curriculum